AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Stemtech Corporation

$0 -$0.00 (-88.89%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0.02
Market Cap
216.93K
AVG Volume
29.71M
Trailing/Forward PE
-0.01/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
02M4M6M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
STEK Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q22.4M
26 Q12.47M
25 Q42.88M
25 Q33.73M
25 Q23.91M
25 Q14.54M
24 Q45.05M
24 Q35.1M
24 Q25.37M
24 Q15.17M
Net Income (USD) · TTM
-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
STEK Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2-3.84M
26 Q1-3.84M
25 Q4-4.04M
25 Q3-2.95M
25 Q2-3.32M
25 Q1-3.81M
24 Q4-3.77M
24 Q3-5.24M
24 Q2-5.11M
24 Q1-4.61M
Operating Income (USD) · TTM
-4M-3M-2M-1M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
STEK Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2-2.42M
26 Q1-2.6M
25 Q4-2.71M
25 Q3-1.81M
25 Q2-2.19M
25 Q1-2.58M
24 Q4-2.39M
24 Q3-3.85M
24 Q2-3.71M
24 Q1-3.98M
EBITDA (USD) · TTM
-4M-3M-2M-1M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
STEK EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2-2.32M
26 Q1-2.41M
25 Q4-2.46M
25 Q3-1.49M
25 Q2-1.67M
25 Q1-2.14M
24 Q4-1.78M
24 Q3-3.13M
24 Q2-3.04M
24 Q1-504.15K
Cash Flows (USD) · TTM
-3M-2M-1M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
STEK Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2-329.99K
26 Q1-200.19K
25 Q4-484.81K
25 Q3-1.63M
25 Q2-2.08M
25 Q1-2.33M
24 Q4-601.2K
24 Q3-699.89K
24 Q2-282.59K
24 Q1-430.26K
EPS (USD) · TTM
-0.06-0.04-0.02024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
STEK EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q2-0.01
26 Q1-0.02
25 Q4-0.02
25 Q3-0.02
25 Q2-0.02
25 Q1-0.03
24 Q4-0.04
24 Q3-0.05
24 Q2-0.05
24 Q1-0.05
Expenses (USD) · TTM
02M4M6M8MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
STEK Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q24.06M
26 Q14.24M
25 Q44.58M
25 Q34.29M
25 Q24.65M
25 Q15.35M
24 Q45.33M
24 Q36.6M
24 Q26.55M
24 Q16.85M
Shares Outstanding (USD) · TTM
-1.5M-1M-500K0500KBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
STEK Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2-439.06K
26 Q1-439.05K
25 Q4-439.05K
25 Q3147.34K
25 Q2-426.78K
25 Q1-439.05K
24 Q4-440.26K
24 Q3-1.03M
24 Q2-452.53K
24 Q1-440.26K
PE Ratio
0.20.220.240.260.28med 0.23Sep 23Sep 23Sep 23Oct 23Oct 23Nov 23Nov 23
STEK PE Ratio by quarter
PeriodPE Ratio
Nov 230.22
Nov 230.22
Nov 230.21
Nov 230.21
Oct 230.21
Oct 230.23
Oct 230.24
Oct 230.25
Sep 230.24
Sep 230.23
Sep 230.27
Sep 230.27
Sep 230.25
Aug 230.23
Free Cash Flow Yield
-20000%-15000%-10000%-5000%0%med -117.92%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
STEK Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-158.84%
Sep 26-15884.22%
Aug 26-158.84%
Aug 26-158.84%
Aug 26-158.84%
Aug 26-246.5%
Jul 26-246.5%
Jul 26-246.5%
Jul 26-246.5%
Jul 26-246.5%
Jul 26-246.5%
Jun 26-246.5%
Jun 26-1427.44%
Jun 26-1427.44%
Jun 26-1427.44%
May 26-1427.44%
May 26-10861.12%
May 26-5430.56%
May 26-5430.56%
May 26-3620.37%
Apr 26-5430.56%
Apr 26-5430.56%
Apr 26-4344.45%
Apr 26-10861.12%
Mar 26-5430.56%
Mar 26-5430.56%
Mar 26-4344.45%
Mar 26-3620.37%
Feb 26-3620.37%
Feb 26-2715.28%
Feb 26-2715.28%
Feb 26-2172.22%
Jan 26-1974.75%
Jan 26-1810.19%
Jan 26-1810.19%
Jan 26-1751.79%
Jan 26-1206.79%
Dec 25-1086.11%
Dec 25-835.47%
Dec 25-724.07%
Dec 25-603.4%
Nov 25-603.4%
Nov 25-638.89%
Nov 25-663.06%
Nov 25-455.86%
Oct 25-416.78%
Oct 25-217.72%
Oct 25-291.75%
Oct 25-177.9%
Oct 25-112.21%
Sep 25-94.11%
Sep 25-123.62%
Sep 25-106.32%
Sep 25-104.2%
Aug 25-85.31%
Aug 25-67.22%
Aug 25-76.29%
Aug 25-71.62%
Aug 25-66.74%
Jul 25-72.95%
Jul 25-70.94%
Jul 25-20.57%
Jul 25-17.17%
Jun 25-18.2%
Jun 25-16.92%
Jun 25-17.59%
Jun 25-14.51%
May 25-14.42%
May 25-16.59%
May 25-18.74%
May 25-28.53%
May 25-25.24%
Apr 25-23.69%
Apr 25-23.74%
Apr 25-22.33%
Apr 25-20.02%
Mar 25-16.61%
Mar 25-16.68%
Mar 25-14.88%
Mar 25-15.27%
Feb 25-14.87%
Feb 25-14.09%
Feb 25-14.62%
Feb 25-14.7%
Jan 25-13.04%
Jan 25-13.52%
Jan 25-12.35%
Jan 25-15.22%
Jan 25-11.43%
Dec 24-12.61%
Dec 24-12.2%
Dec 24-12.28%
Dec 24-11.61%
Nov 24-11.61%
Nov 24-10.61%
Nov 24-9.84%
Nov 24-10.08%
Nov 24-8.98%
Oct 24-6.25%
Oct 24-6.21%
Price to Sales
00.511.5med 0.45Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
STEK Price to Sales by quarter
PeriodPrice to Sales
Sep 260.09
Sep 260
Aug 260.09
Aug 260.09
Aug 260.09
Aug 260.03
Jul 260.03
Jul 260.03
Jul 260.03
Jul 260.03
Jul 260.03
Jun 260.03
Jun 260.01
Jun 260.01
Jun 260.01
May 260.01
May 260
May 260.01
May 260.01
May 260.01
Apr 260.01
Apr 260.01
Apr 260.01
Apr 260
Mar 260.01
Mar 260.01
Mar 260.01
Mar 260.01
Feb 260.01
Feb 260.02
Feb 260.02
Feb 260.02
Jan 260.02
Jan 260.02
Jan 260.02
Jan 260.02
Jan 260.04
Dec 250.04
Dec 250.05
Dec 250.06
Dec 250.07
Nov 250.07
Nov 250.07
Nov 250.08
Nov 250.12
Oct 250.13
Oct 250.24
Oct 250.18
Oct 250.3
Oct 250.47
Sep 250.56
Sep 250.43
Sep 250.5
Sep 250.51
Aug 250.62
Aug 250.79
Aug 250.67
Aug 250.72
Aug 250.77
Jul 250.7
Jul 250.72
Jul 250.58
Jul 250.69
Jun 250.75
Jun 250.81
Jun 250.78
Jun 250.95
May 250.95
May 250.83
May 250.73
May 250.48
May 250.54
Apr 250.58
Apr 250.58
Apr 250.61
Apr 250.69
Mar 250.83
Mar 250.82
Mar 250.92
Mar 250.9
Feb 250.92
Feb 250.97
Feb 250.94
Feb 250.93
Jan 251.05
Jan 251.02
Jan 251.11
Jan 250.9
Jan 251.2
Dec 241.09
Dec 241.12
Dec 241.12
Dec 241.18
Nov 241.18
Nov 241.29
Nov 240.54
Nov 240.52
Nov 240.59
Oct 240.84
Oct 240.85
EV/EBITDA
0100200300med 5.14Jan 22Apr 22Jul 22Oct 23Jan 24Apr 24Jul 24
STEK EV/EBITDA by quarter
PeriodEV/EBITDA
Jul 24196.56
Jul 244.19
Jun 244.39
Jun 244.18
Jun 244.08
Jun 243.71
May 243.92
May 243.87
May 244.07
May 244.4
May 244.45
Apr 244.63
Apr 244.71
Apr 245.26
Apr 245.01
Mar 245.27
Mar 246.47
Mar 243.99
Mar 243.42
Mar 242.92
Feb 242.96
Feb 242.89
Feb 242.97
Feb 242.99
Jan 242.96
Jan 242.9
Jan 242.94
Jan 243.01
Dec 233.09
Dec 233.03
Dec 232.96
Dec 233.06
Dec 232.76
Nov 230.25
Nov 230.25
Nov 230.24
Nov 230.24
Oct 230.25
Oct 230.26
Oct 230.26
Oct 230.27
Sep 230.26
Sep 230.26
Sep 230.28
Sep 230.28
Sep 230.27
Aug 230.26
Aug 22165.5
Aug 22183.44
Aug 22255.22
Jul 22192.12
Jul 22259.71
Jul 22203.48
Jul 22155.33
Jul 22150.55
Jun 22150.55
Jun 22150.55
Jun 2290.73
Jun 2290.73
May 2290.73
May 2290.73
May 2257.23
May 2257.23
Apr 2260.89
Apr 2263.32
Apr 2263.32
Apr 2252.15
Apr 2252.15
Mar 2249.17
Mar 2239.49
Mar 2239.29
Mar 2258.46
Feb 2248.18
Feb 2242.85
Feb 2239.69
Feb 2238.9
Jan 2238.9
Jan 2238.9
Jan 2239.1
Jan 2238.9
Dec 2146.21
Dec 2168.53
Dec 2125.27
Dec 2158.06
Dec 2157.87
Nov 2158.66
Stemtech Corporation
STEK
Stockpicker

Video analysis: STEK

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: STEK

Stemtech Corporation Appoints Alejandro Carrillio President, Latin Markets

accessnewswire.com · 20 Aug 2026

Stemtech Corporation Appoints Alejandro Carrillio President, Latin Markets

LIVE LONGER - LIVE BETTER - LIVE YOUNGER NAPLES, FL / ACCESS Newswire / August 20, 2026 / Stemtech Corporation (OTCID:STEK), the global leader and pioneer in stem cell nutrition (stemceutical™) products, today announced the appointment of Alejandro Carrillo to President, Latin Markets. Carrillo most recently served as Vice President of Global Sales, and his appointment reflects the company's continued investment in the leadership driving its strongest-performing market segment.

Stemtech Corporation Declares July 2026 "Cellular Health Awareness Month"

accessnewswire.com · 1 Jul 2026

Stemtech Corporation Declares July 2026 "Cellular Health Awareness Month"

Spotlighting Two Decades of Natural Regenerative Support, Anti-Aging and Longevity Science, AI-Recognized Pioneer-Leader in Stem Cell Nutrition Marks 20 Years of All-Natural, Plant-Based Stemceuticals™ With a Company-Wide Education Initiative NAPLES, FL / ACCESS Newswire / July 1, 2026 / Stemtech Corporation (OTCID:STEK), the global pioneer and leader in stem cell nutrition, today announced that it has designated July 2026 as Cellular Health Awareness Month, a company-wide initiative dedicated to educating consumers, Independent Business Partners (IBPs), and the wellness community on the science of natural regenerative support, healthy aging, and longevity. "Live Longer - Live Better - Live Younger" For two decades, Stemtech has championed an all-natural, plant-based approach to cellular wellness - long before "longevity" became a mainstream conversation.

Stemtech Corporation Issues 2025 Year-In-Review Letter Highlighting Corporate Strength, Global Expansion and Accelerating Market Opportunities

accessnewswire.com · 23 Jun 2026

Stemtech Corporation Issues 2025 Year-In-Review Letter Highlighting Corporate Strength, Global Expansion and Accelerating Market Opportunities

LIVE LONGER - LIVE BETTER - LIVE YOUNGER Newly Secured Inventory Funding and Global Expansion Position the Company for Scalable Growth Amid Accelerating Demand NAPLES, FL / ACCESS Newswire / June 23, 2026 / Stemtech Corporation (OTCID:STEK), a The Pioneer and global leader in stem cell nutrition and plant-based wellness solutions, today issued a joint letter to shareholders from Chairman and Chief Executive Officer Charles S. Arnold and President and Chief Operating Officer John W.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.